Chimeric oligodeoxynucleotide analogs: chemical synthesis, purification, and molecular and cellular biology protocols.
Giles
R V
RV
Department of Haematology, University of Liverpool, Royal Liverpool University Hospital, United Kingdom.
Spiller
D G
DG
Tidd
D M
DM
D001483:Base Sequence; D002678:Chimera; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D002852:Chromatography, Ion Exchange / Q000379:methods; D018274:Electroporation / Q000379:methods; D004926:Escherichia coli / Q000201:enzymology; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007202:Indicators and Reagents; D007938:Leukemia; D009692:Nucleic Acid Heteroduplexes; D020319:Oligodeoxyribonucleotides, Antisense / Q000138:chemical synthesis* / Q000302:isolation & purification / Q000494:pharmacology*; D016133:Polymerase Chain Reaction / Q000379:methods; D012313:RNA / Q000235:genetics; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D016914:Ribonuclease H / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects*; D014407:Tumor Cells, Cultured
D007202:Indicators and Reagents; D009692:Nucleic Acid Heteroduplexes; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D012313:RNA; D016914:Ribonuclease H